A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Tramadol (Primary) ; Moxifloxacin
- Indications Pain
- Focus Adverse reactions
- Sponsors Janssen
- 25 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2015 Status changed from recruiting to active, no longer recruiting , as reported by ClinicalTrials.gov.
- 12 Apr 2015 Planned End Date changed from 1 Dec 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.